TP53 and neoplasm: Activation of the p53 pathway enhances tumor immunogenicity by upregulating antigen presentation machinery (e.g., MHC class II), inducing interferon signaling, and promoting IL-15 expression and T-cell infiltration (Zhao et al., 2025).